Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-1-10
pubmed:abstractText
The amyloid precursor protein (APP) of Alzheimer's disease (AD) has a copper binding domain (CuBD) located in the N-terminal cysteine-rich region that can strongly bind copper(II) and reduce it to Cu(I) in vitro. The CuBD sequence is similar among the APP family paralogs [amyloid precursor-like proteins (APLP1 and APLP2)] and its orthologs (including Drosophila melanogaster, Xenopus laevis, and Caenorhabditis elegans), suggesting an overall conservation in its function or activity. The APP CuBD is involved in modulating Cu homeostasis and amyloid beta peptide production. In this paper, we demonstrate for the first time that Cu-metallated full-length APP ectodomain induces neuronal cell death in vitro. APP Cu neurotoxicity can be induced directly or potentiated through Cu(I)-mediated oxidation of low-density lipoprotein, a finding that may have important implications for the role of lipoproteins and membrane cholesterol composition in AD. Cu toxicity induced by human APP, Xenopus APP, and APLP2 CuBDs is dependent on conservation of histidine residues at positions corresponding to 147 and 151 of human APP. Intriguingly, APP orthologs with different amino acid residues at these positions had dramatically altered Cu phenotypes. The corresponding C. elegans APL-1 CuBD, which has tyrosine and lysine residues at positions 147 and 151, respectively, strongly protected against Cu-mediated lipid peroxidation and neurotoxicity in vitro. Replacement of histidines 147 and 151 with tyrosine and lysine residues conferred this neuroprotective Cu phenotype to human APP, APLP2, and Xenopus APP CuBD peptides. Moreover, we show that the toxic and protective CuBD phenotypes are associated with differences in Cu binding and reduction. These studies identify a significant evolutionary change in the function of the CuBD in modulating Cu metabolism. Our findings also suggest that targeting of inhibitors to histidine residues at positions 147 and 151 of APP could significantly alter the oxidative potential of APP.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1529-2401
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
365-76
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11784781-Alzheimer Disease, pubmed-meshheading:11784781-Amyloid beta-Protein Precursor, pubmed-meshheading:11784781-Animals, pubmed-meshheading:11784781-Binding Sites, pubmed-meshheading:11784781-Caenorhabditis elegans, pubmed-meshheading:11784781-Cells, Cultured, pubmed-meshheading:11784781-Conserved Sequence, pubmed-meshheading:11784781-Copper, pubmed-meshheading:11784781-Drosophila, pubmed-meshheading:11784781-Glycine, pubmed-meshheading:11784781-Humans, pubmed-meshheading:11784781-Lipid Peroxidation, pubmed-meshheading:11784781-Lipoproteins, LDL, pubmed-meshheading:11784781-Mice, pubmed-meshheading:11784781-Mutagenesis, Site-Directed, pubmed-meshheading:11784781-Neurons, pubmed-meshheading:11784781-Organometallic Compounds, pubmed-meshheading:11784781-Oxidation-Reduction, pubmed-meshheading:11784781-Peptide Fragments, pubmed-meshheading:11784781-Protein Structure, Tertiary, pubmed-meshheading:11784781-Recombinant Proteins, pubmed-meshheading:11784781-Sequence Homology, Amino Acid, pubmed-meshheading:11784781-Species Specificity, pubmed-meshheading:11784781-Structure-Activity Relationship, pubmed-meshheading:11784781-Takifugu, pubmed-meshheading:11784781-Xenopus
pubmed:year
2002
pubmed:articleTitle
Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein.
pubmed:affiliation
Department of Pathology, The University of Melbourne, Victoria 3010, Australia.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't